Tracy Han
Papers
1
Total Citations
10
H-Index
1
About
Tracy Han is a urologic oncologist whose research focuses on improving risk stratification and treatment decisions for prostate cancer. Her most-cited work, a 2017 study on Gleason 8 prostate cancer, demonstrated that over half of patients classified as high-risk based on contemporary biopsy findings were actually downgraded to lower-risk disease after radical prostatectomy. This finding critically challenged clinical guidelines that rely on the highest Gleason score from any single biopsy core, suggesting that many men may be overtreated for what is ultimately less aggressive cancer. With 10 citations, this paper has influenced the ongoing debate about biopsy interpretation and active surveillance protocols. Han's contributions lie at the intersection of pathology and clinical decision-making, helping to refine how urologists interpret biopsy results to avoid unnecessary aggressive treatment. Her work underscores the importance of integrating multiple biopsy parameters—rather than relying solely on the highest Gleason score—to better predict true pathological outcomes and improve personalized care for prostate cancer patients.
Research Focus
Key Achievements
Top Papers
- 1